Prof. Oya Tagit, University of Applied Sciences and Arts Northwestern Switzerland, will be the guest at the Nano Open Webinar on Wednesday, March 26, 2025 between 11.00-12.00 at Zoom.
Prof. Oya Tagit, will talk about give an overview of the development and scale-up manufacturing of PLGA-based nanomedicines for cancer immunotherapy.
Nanomedicines based on poly(lactic-co-glycolic acid) (PLGA) carriers offer tremendous opportunities for biomedical research. Although several PLGA-based systems have already been approved by both the Food and Drug Administration (FDA) and the European Medicine Agency (EMA), and are widely used in the clinics for the treatment or diagnosis of diseases, no PLGA nanomedicine formulation is currently available on the global market. One of the most impeding barriers is the development of a manufacturing technique that allows for the transfer of nanomedicine production from the laboratory to an industrial scale with proper characterization and quality control methods.
To register for the Nano Open Webinar, which will be held on Zoom on March 26, 2025, at 11:00: http://otolab.sabanciuniv.edu/SUNUMActivityRegistrationForm
Webinar will be held in English.
About Prof. Oya Tagit
Prof. Oya Tagit obtained her PhD at the MESA+ Institute for Nanotechnology, University of Twente, The Netherlands. Following a career in academia and industry in a highly international landscape (France, Singapore, Ireland), she is currently leading the Group of Biointerfaces at FHNW and is a member of the Swiss Nanoscience Institute Executive Committee. The group of BioInterfaces aims to address currently unmet biomedical needs in the diagnosis, monitoring, and treatment of disease with engineered nanoparticles tailored for the desired biological targets and functions. An interdisciplinary approach at the interface between materials chemistry, nanotechnology, and biology is utilized for bench-to-bedside development of optical and magnetic detection probes, (pre-)clinical imaging agents, and drug delivery systems based on inorganic and polymeric nanoparticles. The diagnostic and therapeutic performance of these nanoparticles are studied in vitro and in vivo using advanced imaging and cell culture techniques and disease models.